- Letter from the President
- From the Executive Director/CEO
- Q&A with Alison Christy, MD, PhD
- 2025 54th CNS Annual Meeting Photo Gallery
- Three Synapses
- Letter from the Child Neurology Foundation President
- CNS 2025 Corporate Partners
- Meet Kaue – Living with XLMTM – Sponsored Content
- The Benefits of a Multimodal Treatment Approach in Duchenne Muscular Dystrophy – Sponsored Content
- OPAL Trial: Evaluating Apitegromab in Patients Aged <2 years with Spinal Muscular Atrophy – Sponsored Content
Bringing CNS Members Together to Make Children’s Lives Better